-
Drugs
-
Naproxen Information
FDA Alert: Based on emerging information from a long-term prevention trial, the risk of cardiovascular and cerebrovascular events may increase among patients taking naproxen. FDA will be analyzing all available information from these studies to determine whether additional regulatory action is needed.
1/10/2005
-
Healthcare Professional Information
-
-
Other Information
-
-
Historical Information
- Naproxen Historical Patient Information Sheet from 2004 (PDF - 34KB)
(includes FDA Alert from 12/23/2004) - Naproxen Information - Healthcare Professional Sheet pdf (PDF - 36KB)
(includes FDA Alert from 12/23/2004
-
-
-